Correlation Between Virax Biolabs and Ginkgo Bioworks

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Ginkgo Bioworks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Ginkgo Bioworks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Ginkgo Bioworks Holdings, you can compare the effects of market volatilities on Virax Biolabs and Ginkgo Bioworks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Ginkgo Bioworks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Ginkgo Bioworks.

Diversification Opportunities for Virax Biolabs and Ginkgo Bioworks

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Virax and Ginkgo is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Ginkgo Bioworks Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ginkgo Bioworks Holdings and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Ginkgo Bioworks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ginkgo Bioworks Holdings has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Ginkgo Bioworks go up and down completely randomly.

Pair Corralation between Virax Biolabs and Ginkgo Bioworks

Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 1.22 times more return on investment than Ginkgo Bioworks. However, Virax Biolabs is 1.22 times more volatile than Ginkgo Bioworks Holdings. It trades about -0.06 of its potential returns per unit of risk. Ginkgo Bioworks Holdings is currently generating about -0.08 per unit of risk. If you would invest  228.00  in Virax Biolabs Group on August 26, 2024 and sell it today you would lose (27.00) from holding Virax Biolabs Group or give up 11.84% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Virax Biolabs Group  vs.  Ginkgo Bioworks Holdings

 Performance 
       Timeline  
Virax Biolabs Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Virax Biolabs Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Ginkgo Bioworks Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ginkgo Bioworks Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ginkgo Bioworks is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Virax Biolabs and Ginkgo Bioworks Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Virax Biolabs and Ginkgo Bioworks

The main advantage of trading using opposite Virax Biolabs and Ginkgo Bioworks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Ginkgo Bioworks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will offset losses from the drop in Ginkgo Bioworks' long position.
The idea behind Virax Biolabs Group and Ginkgo Bioworks Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios